Literature DB >> 3316135

Monomorphic anti-HLA monoclonal antibody (W6/32) recognizes polymorphic H-2 heavy-chain determinants exposed by association with bovine or human but not murine beta 2-microglobulin.

F Kievits1, P Ivanyi.   

Abstract

W6/32 is a mouse anti-HLA class I monoclonal antibody (MoAb) of BALB/c (H-2d) origin with a monomorphic reaction pattern on human cells. In this study, we explain that the previously reported (Ivanyi D et al., Immunogenetics 20:6gg, 1984) cross-reactions of W6/32 with the H-2Db antigen are completely dependent on the formation of a complex between the H-2Db heavy chain with bovine beta 2-microglobulin (beta 2m) from the culture medium. M0Ab W6/32 cross-reacted with various H-2 class I antigens only in the presence of bovine or human beta 2m but not in the presence of beta 2m from other species (goat, sheep, rabbit) or syngeneic mouse beta 2m. The exposure of the W6/32 determinant on mouse cells was dependent on the concentration of human or bovine beta 2m and was influenced by the temperature and time of incubation. The reaction pattern of W6/32 on a large panel of mouse strains showed that the binding is due to at least two critical factors: (i) the H-2 haplotype of the target cells; and (ii) the substitution of murine beta 2m for bovine or human beta 2m. These results show that exposure of a polymorphic class I determinant is dependent on the species origin of beta 2m with which the heavy chain is complexed. Comparison of beta 2m amino acid sequences from various species does not give a clear answer about the shared quality of human and bovine beta 2m. One amino acid position (89) was identified at which human and bovine beta 2m are identical but differ from all other known beta 2m sequences.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316135     DOI: 10.1016/0198-8859(87)90026-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

1.  Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.

Authors:  Yvonne M Saenger; Yanyun Li; Karoline C Chiou; Brian Chan; Gabrielle Rizzuto; Stephanie L Terzulli; Taha Merghoub; Alan N Houghton; Jedd D Wolchok
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

2.  Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.

Authors:  W J Storkus; J Alexander; J A Payne; J R Dawson; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  Real and apparent H-2-specific antibodies induced by syngeneic immunization.

Authors:  A Rocca; A Opolski; B Frangoulis; L Degos; M Pla
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Immunization with syngeneic Sendai virus-infected cells induce no MHC-restricted antibodies but antibodies specific for H-2 class I determinants.

Authors:  F Kievits; W J Boerenkamp; P Ivanyi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Sequence of beta(2)-microglobulin from rhesus macaque ( Macaca mulatta) includes an allelic variation in the 3'-untranslated region.

Authors:  Jin Su; Mark A Luscher; Kelly S MacDonald
Journal:  Immunogenetics       Date:  2004-02-12       Impact factor: 2.846

6.  Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.

Authors:  A Vitiello; D Marchesini; J Furze; L A Sherman; R W Chesnut
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

7.  Murine xenograft bioreactors for human immunopeptidome discovery.

Authors:  James M Heather; Paisley T Myers; Feng Shi; Mohammad Ovais Aziz-Zanjani; Keira E Mahoney; Matthew Perez; Benjamin Morin; Christine Brittsan; Jeffrey Shabanowitz; Donald F Hunt; Mark Cobbold
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

Review 8.  Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Carly J Amato-Menker; Hajar El Hilali; Senthamil R Selvan; Edward J Filippone
Journal:  Antibodies (Basel)       Date:  2022-09-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.